CAMP4 Therapeutics Corporation
CAMPNASDAQHealthcare● Active
$4.23
+$0.14(+3.30%)
Market Cap$89739942
P/E Ratio—
52W High$7.75
52W Low$1.305
CAMP4 Therapeutics Corporation (CAMP) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CAMP · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-11 | 2023-02 | 2022-02 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $3.50M | $0.65M | $0.35M | $0.00M | $295.84M |
| Cost of Revenue | $1.64M | $0.00M | $0.00M | $0.00M | $173.95M |
| Gross Profit | $1.86M | $0.65M | $0.35M | $0.00M | $121.89M |
| Gross Margin %(computed) | 53.14% | 100.00% | 100.00% | — | 41.20% |
| Operating Expenses | |||||
| R&D Expenses | $38.20M | $38.82M | $40.62M | $34.77M | $28.44M |
| G&A Expenses | $17.36M | $14.92M | $11.61M | $10.23M | $52.33M |
| Total Operating Expenses | $53.92M | $53.74M | $52.23M | $45.00M | $134.76M |
| Operating Income | ($52.06M) | ($53.09M) | ($51.88M) | ($45.00M) | ($15.31M) |
| Operating Margin %(computed) | — | — | — | — | -5.18% |
| Interest Income | $2.17M | $1.33M | $2.81M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $6.26M | $15.32M |
| Income Before Tax | ($80.40M) | ($51.79M) | ($49.29M) | ($44.19M) | ($30.06M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $1.09M |
| Net Income | ($80.40M) | ($51.79M) | ($49.29M) | ($44.19M) | ($31.15M) |
| Net Margin %(computed) | — | — | — | — | -10.53% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.65 | $-2.66 | $-4.07 | $-0.90 | $-0.88 |
| Wtd Avg Shares | 30.38M | 19.51M | 12.12M | 36.10M | 35.25M |
| EBITDA | ($50.42M) | ($51.39M) | ($50.20M) | ($44.12M) | $7.49M |
| EBITDA Margin %(computed) | — | — | — | — | 2.53% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more CAMP4 Therapeutics Corporation data
About CAMP4 Therapeutics Corporation (CAMP) Income Statement
CAMP4 Therapeutics Corporation (CAMP) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CAMP reported revenue of $0.00B, gross profit of $0.00B (gross margin 53.14%), and net income of ($0.08B) — a net profit margin of -2298.54%.
Frequently asked questions
CAMP · 4 questionsCAMP4 Therapeutics Corporation (CAMP) reported revenue of $0.00B for 2025, up 436.5% year-over-year.
CAMP revenueCAMP salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09